After completing this activity, pharmacists should be able to:
- Describe the symptoms and signs of post-herpetic neuralgia
- Outline the risks for developing post-herpetic neuralgia, and the prognosis
- Describe the identification of post-herpetic neuralgia and the treatment challenges
- Describe pharmacotherapy for post-herpetic neuralgia, and the role of pharmacists in improving treatment adherence.
The 2010 Competency Standards addressed by this activity include: 1.3, 2.3, 4.2, 4.3, 6.1, 7.1, 7.2, 7.3
The 2016 Competency Standards addressed by this activity include: 2.1, 2.2, 3.1, 3.2, 3.3, 3.5
Accreditation number: A1809RP1 Accreditation expires: 1/9/2020
This activity has been accredited for 1.0 hour of Group One CPD (or 1.0 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1.0 hour of Group Two CPD (or 2.0 CPD credits) upon successful completion of the associated assessment activity.